Reduction of polypharmacy in epileptic patients

Area of Science:

• Neurology
• Clinical Pharmacy

Background:

• Polypharmacy is common in epilepsy management.
• Reducing the number of antiepileptic drugs can potentially decrease side effects and improve patient adherence.

Purpose of the Study:

• To assess the feasibility and outcomes of reducing polypharmacy in patients with epilepsy.
• To evaluate the impact on seizure control and adverse events.

Main Methods:

• A prospective study involving 90 epileptic patients undergoing polypharmacy reduction.
• Patients were followed for at least 16 months post-reduction.
• Data collected included drug regimen changes, seizure frequency, and side effects.

Main Results:

• Polypharmacy was successfully reduced in 72 patients (80%), decreasing the average number of drugs from 2.75 to 1.49.
• Seizure control remained stable or improved in most patients, with a decrease in side effects.
• Reduction was unsuccessful in 18 patients (20%), with some requiring additional drugs or returning to the original regimen, particularly those with multiple seizure types.

Conclusions:

• Reducing polypharmacy is a viable strategy for many epilepsy patients, often leading to improved outcomes.
• The presence of multiple seizure types is a significant predictor of unsuccessful polypharmacy reduction in epilepsy.